Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

OpenSAFELY: a platform for analysing electronic health records designed for reproducible research

Nab L. et al, (2024)

Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study

DeVito NJ. et al, (2024), BMJ Medicine, 3, e000738 - e000738

Barriers and Best Practices to Improving Clinical Trials Transparency at UK Public Research Institutions: A qualitative interview study

DeVito NJ. et al, (2024), Health Policy, 104991 - 104991

Completeness and consistency of primary outcome reporting in COVID-19 publications in the early pandemic phase: a descriptive study

Stoll M. et al, (2023), BMC Medical Research Methodology, 23

Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study.

Salholz-Hillel M. et al, (2023), BMC Med, 21

Preventable deaths involving opioids in England and Wales, 2013-2022: a systematic case series of coroners' reports

Dernie F. et al, (2023), Journal of public health (Oxford, England), 45, e656 - e663

Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform

Costello RE. et al, (2023), eClinicalMedicine, 61

Increasing the Reporting Quality of Clinical Trials-No Easy Solutions?

Devito NJ., (2023), JAMA Network Open, 6

Research, promotion, and practice of open science at the Bennett Institute

Morley J. and DeVito N., (2023), proceedings 2022

Estimating the effect of COVID-19 on trial design characteristics: A registered report

Smith JA. et al, (2023), Royal Society Open Science, 10

Generative AI for medical research

Morley J. et al, (2023), BMJ

New UK clinical trials legislation will prioritise transparency

Devito NJ. and Goldacre B., (2023), BMJ

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY.

Green ACA. et al, (2023), BMJ Med, 2

Preventable deaths involving opioids in England and Wales, 2013-2022: a systematic case series of coroners’ reports

Dernie F. et al, (2022)

Sharing study materials in health and medical research.

DeVito NJ. et al, (2022), BMJ Evid Based Med

Software development skills for health data researchers

Morton C. et al, (2022), BMJ Health and Care Informatics, 29

Issues with reporting and interpretation of Khan et al. 2021.

DeVito NJ. and Drysdale H., (2022), BMC Infect Dis, 22

Improving medical research in the United Kingdom.

Bradley SH. et al, (2022), BMC Res Notes, 15

Trends and variation in data quality and availability on the European Union Clinical Trials Register: A cross-sectional study

DeVito NJ. and Goldacre B., (2022), Clinical Trials, 19, 172 - 183

Trends, variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY

The OpenSAFELY Collaborative None. et al, (2022)

Load More